Product composition, structure, and bioavailability

Food Biophysics

Volumn 3, Issue 2, 2008, Pages 207-212

  Duchateau, Guus S M J E ^a   Klaffke, Werner ^a  

^a UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

Author keywords

Bioaccessibility; Bioavailability; Functional foods; Structure

Indexed keywords

EID: 43749123447     PISSN: 15571858     EISSN: 15571866     Source Type: Journal    
DOI: 10.1007/s11483-008-9076-5     Document Type: Article

References (17)

1. 1. L. Allen, B. de Benoist, O. Dary, R.F. Hurrell, Guidelines on Food Fortification with Micronutrients. (World Health Organization and Food and Agriculture Organization of the United Nations, Geneva, 2006) ISBN 92 4 159401 2
2. 2. M. Vertzoni N. Fotaki E. Kostewicz 2004 Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects J. Pharm. Pharmacol 56 4 453 462 10.1211/0022357022935 1:CAS:528:DC%2BD2cXkt1erurs%3D M. Vertzoni, N. Fotaki, E. Kostewicz et al., Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects J. Pharm. Pharmacol 56 (4), 453–462 (2004)
3. 3. H. Chahinian T. Snabe C. Attias 2006 How gastric lipase, an interfacial enzyme with a Ser-His-Asp catalytic triad, acts optimally at acidic pH Biochemistry 45 3 993 1001 10.1021/bi0518803 1:CAS:528:DC%2BD2MXhtlClsLfJ H. Chahinian, T. Snabe, C. Attias et al., How gastric lipase, an interfacial enzyme with a Ser-His-Asp catalytic triad, acts optimally at acidic pH Biochemistry 45 (3), 993–1001 (2006)
4. 4. L. Kalantzi K. Goumas V. Kalioras 2006 Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies Pharm. Res 23 1 165 176 10.1007/s11095-005-8476-1 1:CAS:528:DC%2BD28Xht1Cltr4%3D L. Kalantzi, K. Goumas, V. Kalioras et al., Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies Pharm. Res 23 (1), 165–176 (2006)
5. 5. J.N. Hunt R. Cash P. Newland 1975 Energy density of food, gastric emptying, and obesity Lancet 2 7941 905 906 10.1016/S0140-6736(75)92133-9 1:STN:280:CSmD2svhvFQ%3D J.N. Hunt, R. Cash, P. Newland, Energy density of food, gastric emptying, and obesity Lancet 2 (7941), 905–906 (1975)
6. 6. J.N. Hunt J.L. Smith C.L. Jiang 1985 Effect of meal volume and energy density on the gastric emptying of carbohydrates Gastroenterology 89 6 1326 1330 1:CAS:528:DyaL28XjtlChtQ%3D%3D J.N. Hunt, J.L. Smith, C.L. Jiang, Effect of meal volume and energy density on the gastric emptying of carbohydrates Gastroenterology 89 (6), 1326–1330 (1985)
7. 7. A. Pal J.G. Brasseur B. Abrahamsson 2007 A stomach road or “Magenstrasse” for gastric emptying J. Biomech 40 6 1202 1210 10.1016/j.jbiomech.2006.06.006 A. Pal, J.G. Brasseur, B. Abrahamsson, A stomach road or “Magenstrasse” for gastric emptying J. Biomech 40 (6), 1202–1210 (2007)
8. 8. D. Fennel Evans, H. Wennerström, The Colloidal Domain: Where Physics, Chemistry, Biology and Technology Meet, 2nd edn. (VCH, New York, 1994)
9. 9. N.L. Trevaskis, W.N. Charman, C.J.H. Porter, Lipid-based delivery systems and intestinal lymphatic drug transport: A mechanistic update. Adv. Drug Deliv. Rev. (2007) DOI 10.1016/j.addr.2007.09.07
10. 10. G.A. Kossena W.N. Charman B.J. Boyd 2005 Influence of the intermediate digestion phases of common formulation lipids on the absorption of a poorly water-soluble drug J. Pharm. Sci 94 3 481 492 10.1002/jps.20260 1:CAS:528:DC%2BD2MXisVWhs7g%3D G.A. Kossena, W.N. Charman, B.J. Boyd et al., Influence of the intermediate digestion phases of common formulation lipids on the absorption of a poorly water-soluble drug J. Pharm. Sci 94 (3), 481–492 (2005)
11. 11. C.A. Lipinski F. Lombardo B.W. Dominy 1997 Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev 23 1–3 3 25 10.1016/S0169-409X(96)00423-1 1:CAS:528:DyaK2sXktlKlsQ%3D%3D C.A. Lipinski, F. Lombardo, B.W. Dominy et al., Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev 23 (1–3), 3–25 (1997)
12. 12. F. Nigsch W. KJaffke S. Miret 2007 In vitro models for processes involved in intestinal absorption Expert Opinion on Drug Metabolism and Toxicology 3 4 545 556 10.1517/17425255.3.4.545 1:CAS:528:DC%2BD2sXptVWjtb0%3D F. Nigsch, W. KJaffke, S. Miret, In vitro models for processes involved in intestinal absorption Expert Opinion on Drug Metabolism and Toxicology 3 (4), 545–556 (2007)
13. 13. S. Lynch 2006 A comparison of methods for estimating the bioavailability of elemental iron food fortificants FASEB. J 20 4 A623 S. Lynch, A comparison of methods for estimating the bioavailability of elemental iron food fortificants FASEB. J 20 (4), A623 (2006)
14. 14. S.A. Sarker L. Davidsson H. Mahmud 2004 Helicobacter pylori infection, iron absorption, and gastric acid secretion in Bangladeshi children Am. J. Clin. Nutr 80 149 153 1:CAS:528:DC%2BD2cXltlKlt7c%3D S.A. Sarker, L. Davidsson, H. Mahmud et al., Helicobacter pylori infection, iron absorption, and gastric acid secretion in Bangladeshi children Am. J. Clin. Nutr 80, 149–153 (2004)
15. 15. E.A. Trautwein G.S.M.J.E. Duchateau Y. Lin 2003 Proposed mechanisms of Cholesterol-lowering action of Plant Sterols European Journal of Lipid Science and Technology 105 171 185 10.1002/ejlt.200390033 1:CAS:528:DC%2BD3sXjtl2ntbY%3D E.A. Trautwein, G.S.M.J.E. Duchateau, Y. Lin et al., Proposed mechanisms of Cholesterol-lowering action of Plant Sterols European Journal of Lipid Science and Technology 105, 171–185 (2003)
16. 16. A.M.E. Doornbos E.M. Meynen G.S.M.J.E. Duchateau 2006 Intake occasion affects the serum cholesterol lowering of a plant sterol-enriched single-dose yoghurt drink in mildly hypercholesterolaemic subjects Eur. J. Clin. Nutr 60 3 325 333 10.1038/sj.ejcn.1602318 1:CAS:528:DC%2BD28XhvVKhsbw%3D A.M.E. Doornbos, E.M. Meynen, G.S.M.J.E. Duchateau et al., Intake occasion affects the serum cholesterol lowering of a plant sterol-enriched single-dose yoghurt drink in mildly hypercholesterolaemic subjects Eur. J. Clin. Nutr 60 (3), 325–333 (2006)
17. 17. J.M.M. van Amelsvoort, G.S.M.J.E. Duchateau, S.M. Mel’nikov et al., WO 2006/069619 A2: Edible compositions comprising a primary lipid, a co-lipid, a physiologically active ingredient and water, and their preparation. (2006), http://www.wipo.int/pctdb/en/wo.jsp?wo=2006069619&IA=WO2006069619&DISPLAY=CLAIMS